All In Biotech

Drug Trial Radar · NCT07406685

The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation

The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation: A Randomized Non-inferiority Trial

Last checked: Nov 20, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

52

Planned (sponsor's estimate)

Start

Aug 20, 2026

Primary completion

Aug 31, 2030

Study completion Oct 31, 2030

Sponsor

Lead sponsor
National Taiwan University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Taiwan University
First posted
Feb 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 50 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a prospective, multicenter, open-label, randomized non-inferiority trial comparing intravenous ibandronate and zoledronic acid as sequential therapy after denosumab discontinuation in postmenopausal women with osteoporosis. This trial primarily targets patients with short-term denosumab exposure (less than three years) and is conducted as a preliminary investigation. The findings are expected to provide foundational evidence to inform the design of future studies assessing sequential therapies following longer-term denosumab treatment.

Conditions

  • Postmenopausal Osteoporosis
  • Postmenopausal Osteopenia
  • Primary Osteoporosis
  • Osteoporosis

Interventions

  • Ibandronate IVDrug

    Ibandronate 3mg/3months for 12 months

  • Zoledronic acid IVDrug

    Zoledronic acid 5mg/1year for 12 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage change in bone mineral density (BMD)Time frame: Baseline to 24 months after treatment initiation.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Taiwan University Hospital

    Taipei, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.